Invivoscribe® Releases LymphoTrack® TRB Assay on MiSeq® and LymphoTrack® Minimal Residual Disease (MRD) Softwarewmm2019-07-04T21:12:43+00:00November 7th, 2017|Categories: Press Releases|Tags: LymphoTrack, LymphoTrack® TRB Assay, Minimal Residual Disease, MiSeq®, MRD, MRD Software| ⟵ PRESS RELEASES PRESS RELEASE SAN DIEGO, [...] Read More
AMP 2016 MRD Solutions for the Studies of Hematologic Malignancies – LymphoTrack® Assaysadmin2019-05-28T17:45:08+00:00November 20th, 2016|Categories: Featured Videos, Videos|Tags: AMP, AMP 2016, Dr. Maria Arcila, Hematologic Malignancies, IGH, LymphoTrack, LymphoTrack Assays, Memorial Sloan-Kettering Cancer Center, Minimal Residual Disease, Molecular Diagnostic Services, Molecular Hematopathology, MRD, NGS, NGS-based LymphoTrack IGH and TRG Assays, TRG|VIEW VIDEO ⟶ Read More
AMP 2014 – Clonality Assessment & Monitoring Using LymphoTrack Next-Generation Sequencing Assaysadmin2019-05-28T17:43:52+00:00November 16th, 2014|Categories: Featured Videos, Videos|Tags: AMP, AMP 2014, Clonality, Clonality Assessment, Clonality Monitoring, Diagnostic Molecular Pathology Laboratory, Dr. Jeffrey Miller, Dr. Maria Arcila, Dr. Michael Klass, Dr. Rina Kansal, LymphoTrack, LymphoTrack Assays, Mememorial Sloan and Kettering Cancer Center, Next-Generation Sequencing, NGS, University of California Los Angeles|VIEW VIDEO ⟶ Read More
